
Mycobacterium [66]


Magdalena Gil-Tarán
Magdalena did a PhD on proteomics and analytical biochemistry at the Institut Pasteur de Montevideo (Uruguay) under the supervision of Dr. Rosario Durán, focused on the characterization of Mycobacterium tuberculosis Ser/Thr kinase PknG signaling […]

Samuel Alvarez Arguesdas
Integrated Mycobacterial Pathogenomics
Samuel Álvarez-Arguedas is doing his PhD in Biochemistry and Molecular Biology at the University of Zaragoza, Spain, under the supervision of Prof. Carlos Martín, focusing on the study and characterization of the new tuberculosis vaccine, […]

TBVAC 2020
Roland Brosch

SUPERCPLX
Marco Bellinzoni

Thomas Laval

Alexandre Giraud–Gatineau
Biology of Spirochetes
Alexandre is a PhD student from the University Paris VII. He is graduated for a Master degree in 2016 from the University Pierre et Marie Curie, Paris. He studied the efficacy of TB drugs encapsulated with […]

Matthias Groschel
Integrated Mycobacterial Pathogenomics
Tuberculosis (TB) affects mostly young people in their most productive years and the long treatment with its many side effects is a challenge for patients. A vaccine that protects better from developing TB or […]

16L-BioFermentor • New Brunswick Scientific / Eppendorf • Bioflo® 510
Production and Purification of Recombinant Proteins Technological Platform
2 • Fermentor • Eppendorf • Bioflo® 310
Production and Purification of Recombinant Proteins Technological Platform
(FR) Tuberculosis Research Laboratory – Institut Pasteur Korea

Inhibitors of TMPK from Mycobacterium tuberculosis
Hélène Munier-Lehmann • Sylvie Pochet

Finding new antimycobacterials, the dibenzofurans story
Yves Janin

Therapeutic potential of mycolactone and synthetic surrogates
Caroline Demangel • Laure Guenin-Mace • Gilles Dadaglio

Immunity against Mycobacterium ulcerans : the subversive role of mycolactone
Caroline Demangel • Laure Guenin-Mace
